Elon Musk testified in the opening day of the OpenAI trial, claiming that greed drove Sam Altman to shift the artificial intelligence lab away from its nonprofit mission. The dispute centers on OpenAI's commercial trajectory and its partnership with Microsoft, which has invested billions in the company's technology.

Musk, a co-founder who departed OpenAI's board, argues that Altman prioritized profit over the lab's original charitable purpose. OpenAI disputes this characterization, maintaining its work serves broader public interests while generating revenue through corporate partnerships.

The trial reflects a deeper tension in the AI industry about balancing innovation with accountability. As artificial intelligence becomes more powerful, questions about governance and profit motives intensify.

Market observers watch closely because the outcome could influence how AI companies structure themselves and seek funding. The dispute matters for investors evaluating whether AI ventures can deliver returns while maintaining ethical standards.